Educational Qualification

• PhD, Pharmaceutical Medicine (Clinical Pharmacology): Jamia Hamdard University, New Delhi, India (2014)
• M.Pharm, Pharmacology: Jamia Hamdard Univeristy, New Delhi, India (2010)
• B.Pharm: Jamia Hamdard University, New Delhi, India (2008)
• Intellectual Property Course - World Intellectual Property Organization (WIPO) Worldwide Academy

Professional Career

• Associate Professor, Department of Clinical Pharmacy & Pharmacology, RAK College of Pharmaceutical Sciences, Ras Al Khaimah, UAE (November 2019 to till date)
• Assistant Professor, Department of Clinical Pharmacy & Pharmacology, RAK College of Pharmaceutical Sciences, Ras Al Khaimah, UAE (October 2014 to October 2019)
• Faculty, Centre for Translational and Clinical Research, Jamia Hamdard University, New Delhi, India (June 2014 to September 2014)
• Assistant Manager, Medical and Scientific Department, Max Neeman International, New Delhi, India (December 2013 to June 2014) 
• Lecturer cum Consultant, Creo Zenith Health, Noida, India (April 2012 to April 2013)
• Lecturer, Institute of Clinical Research India, New Delhi, India (March 2011 to March 2012)
• Research Associate, Research and Development Unit, Ranbaxy Research Laboratories, India (June 2010 to September 2010)

Achievements/Awards (Selected)

• Young Scientist Award for contribution in the field of Clinical Pharmacy and Pharmacology - 2021
• Young Teacher Award for Outstanding Contribution towards Pharmaceutical Education & Research – 2019
• Overall Best Presentation Award 2022 at 5th  Global Public Health Conference (GlobeHeal 2022). Rabbani SA, Shouqair T, Kurian MT. Assessment and Evaluation of Medication Related Problems among Chronic Kidney Disease Patients.
• Best Poster Presentation Award – DUPHAT 2022, Dubai. Safdar M, Imad, I, Azim  MA, Shaar MK, Rabbani SA, Sridhar SB, Rao PGM. Assessment of prescription & dispensing practices in community pharmacies of Ras al Khaimah
• First Prize- Innovation at DUPHAT 2021, Dubai, UAE. Saba MM, Rabbani SA. Development of medication assistive techniques for visually impaired patients.
• First Prize at Student Scientific Conference 2021, RAK Medical and Health Sciences, UAE. Shalabi H, Jawdat D, Salmeh A, Rabbani SA. Effect of Rosmarinus officinalis extract on maximal electroshock induced seizures, cognition and oxidative stress in mice
• Best Poster Presentation Award for research paper titled "Evaluation of Antihypertensive Prescriptions for Rationality and Adherence to Treatment Guidelines: An Experience from a Secondary Care Hospital in United Arab Emirates" at the SPER International Conference 2019 in Bangkok, Thailand
• Best Oral Presentation Award at DUPHAT 2019, Dubai, UAE. AbuDawoud GS, Bara MM, Younes MA. Rabbani SA. Implementation of artificial intelligence (AI) in healthcare
• Best Quality Poster Award at DUPHAT 2018, Dubai, UAE. Marzooqi ASMK, Srouji AEM, Hamad EA, Rabbani SA. Impact of community-based educational intervention on breast cancer and its screening awareness among Arab women in the United Arab Emirates.  
• Best Thematic Poster Award at DUPHAT 2018, Dubai, UAE. Mustafa F, Rabbani SA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Knowledge, Attitude and Practice (KAP) Study among the Students of a Medical and Health Sciences University

Research Interests

• Holistic, collaborative, interdisciplinary approach towards research
• Involved in Clinical, Pre-clinical and Community based research
• Clinical: Pharmacotherapy and Medication Safety: Pharmacoepidemiology and Pharmacovigilance related research
• Pre-clinical: Pharmacokinetic and pharmacodynamic evaluation of drug formulations and natural products
• Community: Community based educational intervention research

Publications

Number of Publications: 47

Research: 33
Review: 12
Book Chapter: 2

Publications (Selected)

• Clinical Characteristics, Risk Factors for Severity and Pharmacotherapy in Hospitalized COVID-19 Patients in the United Arab Emirates. Journal of Clinical Medicine 2022;11(9):2439. Impact Factor: 4.24
• Evaluation of potential drug-drug interactions and adverse drug reactions among chronic kidney disease patients: An experience from United Arab Emirates. Tropical Journal of Pharmaceutical Research. 2022; 21(4):853-861.
• Evaluation of Drug-Related Problems in Chronic Kidney Disease Patients. Cureus Journal of Medical Science. 2022;14(4):e24019.
• Coronavirus disease 2019 (COVID-19) in a kidney transplant recipient; case report. Journal of Nephropathology
• Pharmaceutical care services provided by pharmacists during COVID-19 pandemic: perspectives from around the World. Journal of Pharmaceutical Health Services Research
• Experiential training during COVID-19 pandemic: A virtual attachment experience from a College of Pharmaceutical Sciences in United Arab Emirates. Pharmacy Education – FIP
• Patterns of drug use and polypharmacy burden in chronic kidney disease patients: An experience from a secondary care hospital in United Arab Emirates. International Journal of Clinical Pharmacology and Therapeutics
• Proton pump inhibitor use and appropriateness analysis: a snapshot from a secondary care hospital. Journal of Pharmaceutical Health Services Research
• Prevalence and associations of moderately increased albuminuria in patients with type 2 diabetes in United Arab Emirates. Diabetes & Metabolic Syndrome Journal
• Impact of community-based educational intervention on breast cancer and its screening awareness among Arab women in the United Arab Emirates. Clinical Epidemiology and Global Health
• Book Chapter: Global Submissions for Drug Approvals. Regulatory Affairs in the Pharmaceutical Industry. Elsevier and Academic Press
• Facile functionalization of Teriflunomide-loaded nanoliposomes with Chondroitin sulphate for the treatment of Rheumatoid arthritis. Carbohydrate Polymers. Impact Factor: 9.3
• Nanotechnology Driven Approaches for the Management of Parkinson’s Disease: Current Status and Future Perspectives. Current Drug Metabolism. Impact Factor: 3.7
• Quality by Design driven development and optimization of teriflunomide loaded nanoliposomes for treatment of rheumatoid arthritis: An in vitro and in vivo assessments. Journal of Drug Delivery Science and Technology. Impact Factor: 3.9
• Role of Rutin Nanoemulsion in Ameliorating Oxidative Stress: Pharmacokinetic and Pharmacodynamics Studies. Chemistry and Physics of Lipids. Impact Factor: 3.3
• Novel In-Situ NanoEmulGel (NEG) of Azithromycin with Eugenol for the Treatment of Periodontitis: Formulation Development and Characterization. Journal of Cluster Science. Impact Factor: 3.0

Conferences/Workshops (Selected)

Workshops

• Webinar Guest Lecture on "Implementation of telepharmacy services during the ongoing COVID-19 pandemic" at Amity University, India-2022
• Conducted a workshop on "How to write a research proposal" organized by Centre for Educational Development and Research, RAK Medical & Health Sciences University, Ras Al Khaimah, UAE - 2020
• Conducted a workshop on "Rational Antibiotic Use" organized by Pharmacy Department, Primary Health Care Centre, RAK Medical District at Double Tree Hilton, Ras Al Khaimah, UAE - 2019
• Speaker at 2nd Enteral and Parenteral Nutrition" Conference organized by Ministry of Health and Prevention, RAK Medical District at AURAK, Ras Al Khaimah, UAE - 2019
• Conducted Workshop on Rational Drug Use as part of World Pharmacist Week- organized by Central Medical Store, Ministry of Health and Prevention (MoHP) at Cove Rotana, Ras Al Khaimah, UAE -2019

Conferences 

• Presented Research Paper - "Assessment and Evaluation of Medication Related Problems among Chronic Kidney Disease Patients" at 5th  Global Public Health Conference (GlobeHeal 2022), Sri Lanka.
• Presented Research Paper - "Patterns of Drug Use and Polypharmacy Burden in Chronic Kidney Disease Patients: An Experience from a Secondary Care Hospital in United Arab Emirates" at 6th International Clinical Pharmacy Conference held at Manipal, Karnataka, India -2021
• Presented Research Paper - "Assessment and Evaluation of Adverse Drug Reactions among Chronic Kidney Disease Patients of a Secondary Care Hospital of Ras Al Khaimah" at Oman Pharmaceutical Conference, Muscat, Oman - 2019
• Presented Research Paper - "Evaluation of Antihypertensive Prescriptions for Rationality and Adherence to Treatment Guidelines: An Experience from a Secondary Care Hospital in United Arab Emirates" at SPER International Conference in Bangkok, Thailand -2019
• Presented Research Paper - "Use of phosphate binders in end-stage renal disease patients: An experience from a secondary care hospital in United Arab Emirates" at Annual Meeting of American College of Clinical Pharmacology, Bethesda, Maryland, USA - 2018
• Presented Research Paper- "Hyperphosphatemia in end stage renal disease patients undergoing maintenance hemodialysis at a secondary care hospital in UAE" at International Conference on Public Health, Colombo, Sri Lanka -2018